Detalles de la búsqueda
1.
Assessment of nuclear grade-based recurrence risk classification in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, node-positive high-risk early breast cancer.
Breast Cancer
; 30(6): 1054-1064, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37612443
2.
Prognostic impact of HER2-low positivity in patients with HR-positive, HER2-negative, node-positive early breast cancer.
Sci Rep
; 13(1): 19669, 2023 11 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37952045
Resultados
1 -
2
de 2
1
Próxima >
>>